GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer medicines posted double digit ...

A bold guidance raise, fresh FDA approval, and pipeline deals set the stage for GSK's post-Walmsley transformation.

More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...

Campaigners in Northern Ireland have called for the introduction of a 'game-changing' drug that will prevent HIV. On Friday ...

The findings confirm that allosteric inhibition of integrase is clinically viable, validating a new antiviral drug class.

A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF ...

HIV prevention drug Lenacapavir, which has been tested in South Africa during clinical trials, will be made available in the country in 2026 for high-risk groups.

CVS Caremark, the largest PBM in the U.S., tells activists Gilead needs to lower the price of its new HIV drug to get on ...

KZN to receive Lenacapavir,new long-acting HIV prevention injection. Minister Motsoaledi confirms rollout to 360 clinics, for 6-month protection dose ...

The Lau Provincial Council has launched a taskforce to address the rising cases of HIV and drug use in the province. Speaking ...

GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit ...